X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (43819) 43819
Newsletter (10639) 10639
Newspaper Article (8363) 8363
Book Chapter (368) 368
Magazine Article (265) 265
Book / eBook (218) 218
Government Document (121) 121
Trade Publication Article (103) 103
Web Resource (92) 92
Transcript (91) 91
Dissertation (47) 47
Conference Proceeding (30) 30
Book Review (19) 19
Publication (14) 14
Reference (14) 14
Report (6) 6
Streaming Video (4) 4
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cancer (34415) 34415
humans (28558) 28558
immunotherapy (20782) 20782
immunology (18699) 18699
animals (16409) 16409
oncology (16338) 16338
female (13521) 13521
research (13313) 13313
vaccines (12260) 12260
care and treatment (11328) 11328
cancer vaccines (10854) 10854
mice (10392) 10392
tumors (9943) 9943
antigens (9324) 9324
dendritic cells (9273) 9273
male (7868) 7868
medical research (7581) 7581
t cells (7572) 7572
health aspects (7458) 7458
vaccination (7130) 7130
lymphocytes (6813) 6813
cancer vaccines - immunology (6796) 6796
proteins (6356) 6356
oncology, experimental (6008) 6008
melanoma (5788) 5788
immune system (5535) 5535
medicine, research & experimental (5520) 5520
middle aged (5188) 5188
adult (5089) 5089
neoplasms - immunology (5056) 5056
cancer therapies (5029) 5029
analysis (4955) 4955
medicine (4890) 4890
expression (4679) 4679
cell line, tumor (4442) 4442
cancer vaccines - therapeutic use (4370) 4370
chemotherapy (4335) 4335
dendritic cells - immunology (4277) 4277
immunization (4165) 4165
neoplasms - therapy (4116) 4116
immune response (4016) 4016
clinical trials (3998) 3998
peptides (3881) 3881
aged (3855) 3855
mice, inbred c57bl (3836) 3836
metastasis (3823) 3823
cervical cancer (3819) 3819
immunotherapy - methods (3743) 3743
antigens, neoplasm - immunology (3734) 3734
research article (3732) 3732
genetic aspects (3705) 3705
multidisciplinary sciences (3603) 3603
human papillomavirus (3576) 3576
cytokines (3568) 3568
drug therapy (3542) 3542
biology (3538) 3538
lymphocytes t (3348) 3348
immunity (3315) 3315
vaccine (3312) 3312
breast cancer (3306) 3306
t-cells (3301) 3301
apoptosis (3298) 3298
infections (3242) 3242
medicine, experimental (3224) 3224
t-lymphocytes - immunology (3162) 3162
gene expression (3105) 3105
antibodies (3101) 3101
science (3049) 3049
cancer research (3020) 3020
cytotoxicity (3016) 3016
antigen (2997) 2997
cell biology (2975) 2975
infectious diseases (2943) 2943
studies (2936) 2936
t-lymphocytes, cytotoxic - immunology (2931) 2931
biotechnology & applied microbiology (2860) 2860
in-vivo (2795) 2795
cd8-positive t-lymphocytes - immunology (2747) 2747
patients (2747) 2747
therapy (2740) 2740
infection (2727) 2727
review (2681) 2681
mice, inbred balb c (2601) 2601
cells (2510) 2510
viruses (2490) 2490
prevention (2449) 2449
papillomavirus infections (2345) 2345
treatment outcome (2335) 2335
development and progression (2305) 2305
flow cytometry (2272) 2272
medicine & public health (2246) 2246
prostate cancer (2136) 2136
microbiology (2121) 2121
biochemistry & molecular biology (2114) 2114
t cell receptors (2112) 2112
adolescent (2106) 2106
responses (2092) 2092
inflammation (2082) 2082
deoxyribonucleic acid--dna (2080) 2080
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (62) 62
Online Resources - Online (30) 30
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (14) 14
Collection Dvlpm't (Acquisitions) - Vendor file (12) 12
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
St. Michael's Hospital - Stacks (4) 4
UofT at Mississauga - Stacks (3) 3
Humber River Regional Hospital - Finch Stacks (2) 2
Gerstein Science - Bindery (1) 1
Gerstein Science - Periodical Stacks (1) 1
Gerstein Science - Processing (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Lakeridge Health Sciences - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Reserve desk (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Reference (1) 1
St Josephs Health Centre - Stacks (1) 1
Women's College Hospital - Online (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (63692) 63692
Chinese (254) 254
Japanese (189) 189
French (109) 109
German (101) 101
Spanish (50) 50
Russian (45) 45
Polish (17) 17
Czech (11) 11
Italian (8) 8
Danish (6) 6
Norwegian (5) 5
Hungarian (4) 4
Arabic (3) 3
Portuguese (3) 3
Swedish (3) 3
Dutch (2) 2
Hebrew (2) 2
Slovenian (2) 2
Finnish (1) 1
Hindi (1) 1
Korean (1) 1
Romanian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human Vaccines, ISSN 1554-8600, 03/2011, Volume 7, Issue 3, pp. 313 - 321
.... This builds on two decades of research, starting with transgenic approaches to develop oral vaccines in which antigens or therapeutics can be delivered in processed plant biomass, and progressing... 
Plant-produced | Virus-like particle | Subunit vaccine | Influenza | Transgenic plant | Monoclonal antibody | Recombinant protein | Transient expression | influenza | NICOTIANA-BENTHAMIANA | subunit vaccine | recombinant protein | virus-like particle | TRANSGENIC PLANTS | MONOCLONAL-ANTIBODY | B SURFACE-ANTIGEN | IMMUNOLOGY | EDIBLE VACCINE | transient expression | ORAL IMMUNIZATION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | plant-produced | NON-HODGKINS-LYMPHOMA | VIRUS-LIKE PARTICLES | monoclonal antibody | HEPATITIS-B | transgenic plant | Influenza A Virus, H1N1 Subtype - immunology | Viral Vaccines - biosynthesis | Lymphoma, Non-Hodgkin - immunology | Cancer Vaccines - biosynthesis | Humans | Plants, Genetically Modified - immunology | Glucosylceramidase - immunology | Escherichia coli Vaccines - biosynthesis | Vaccines - immunology | Infant | Clinical Trials as Topic | Hepatitis B Vaccines - biosynthesis | Vaccines, Synthetic - immunology | Enterotoxigenic Escherichia coli - immunology | Rabies Vaccines - immunology | Glucosylceramidase - therapeutic use | Influenza Vaccines - biosynthesis | Rabies Vaccines - biosynthesis | Antibodies - immunology | Norwalk virus - immunology | Newcastle disease virus - immunology | Antibodies, Monoclonal - immunology | Gaucher Disease - drug therapy | Plants - immunology
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 06/2011, Volume 121, Issue 6, pp. 2350 - 2360
Journal Article
Immunology and Cell Biology, ISSN 0818-9641, 05/2012, Volume 90, Issue 5, pp. 540 - 552
Journal Article
Cell (Cambridge), ISSN 0092-8674, 2018, Volume 175, Issue 7, pp. 1744 - 1755.e15
Journal Article
Cancer research (Chicago, Ill.), ISSN 1538-7445, 2013, Volume 73, Issue 12, pp. 3591 - 3603
Tumor progression is facilitated by regulatory T cells (Treg) and restricted by effector T cells. In this study, we document parallel regulation of CD8(+) T... 
DISTINCT MECHANISMS | ONCOLOGY | PROGRAMMED DEATH-1 | IMMUNE ESCAPE | MYELOID-LEUKEMIA | SYNGENEIC MOUSE MODEL | REGULATORY T | GROWTH-FACTOR | CHRONIC VIRAL-INFECTION | ANTITUMOR-ACTIVITY | HUMAN OVARIAN-CANCER | T-Lymphocytes, Regulatory - metabolism | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antibodies, Blocking - pharmacology | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Neoplasms, Experimental - pathology | Flow Cytometry | T-Lymphocytes - metabolism | Neoplasms, Experimental - immunology | CD8-Positive T-Lymphocytes - metabolism | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Cytokines - immunology | Cytokines - metabolism | Cancer Vaccines - administration & dosage | Mice, Inbred C57BL | CD4-Positive T-Lymphocytes - metabolism | Neoplasms, Experimental - therapy | CTLA-4 Antigen - metabolism | Lymphocytes, Tumor-Infiltrating - transplantation | Programmed Cell Death 1 Receptor - metabolism | Combined Modality Therapy | CTLA-4 Antigen - immunology | B7-H1 Antigen - immunology | Cancer Vaccines - immunology | B7-H1 Antigen - metabolism | Animals | Antibodies, Blocking - immunology | T-Lymphocytes - immunology | Mice | Mice, Inbred BALB C | Programmed Cell Death 1 Receptor - immunology | CD8-Positive T-Lymphocytes - immunology | CTLA-4 Antigen - antagonists & inhibitors | Lymphocytes, Tumor-Infiltrating - immunology | Tumor Burden - immunology
Journal Article
Virus research, ISSN 0168-1702, 2017, Volume 231, pp. 166 - 175
•Licensed (2-, 4-, 9-valent) L1 virus-like particle (VLP) HPV vaccines effectively prevent persistent infection and disease... 
HPV infection and disease | Human papillomavirus (HPV) vaccine | Squamous cell cancer (SCC) | Cutaneous and anogenital warts (condylomata) | Minor capsid protein (L2) | Cervical cancer (CxCa) | L1 PROTEIN | CROSS-NEUTRALIZATION | CELL-SURFACE | MINOR CAPSID PROTEIN | INTRAEPITHELIAL NEOPLASIA | HPV-16/18 AS04-ADJUVANTED VACCINE | IN-VITRO | VIROLOGY | VIRUS-LIKE PARTICLES | COMMON NEUTRALIZATION EPITOPE | IMMUNOGENIC DISPLAY | Immunogenicity, Vaccine | Recombinant Fusion Proteins - immunology | Head and Neck Neoplasms - virology | Oncogene Proteins, Viral - chemistry | Papillomaviridae - drug effects | Humans | Vaccination | Cross Protection | Papillomavirus Vaccines - biosynthesis | Uterine Cervical Neoplasms - pathology | Epitopes - immunology | Papillomavirus Infections - pathology | Papillomaviridae - immunology | Capsid Proteins - chemistry | Vaccines, Virus-Like Particle | Capsid Proteins - immunology | Papillomavirus Infections - immunology | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Papillomavirus Vaccines - administration & dosage | Antibodies, Viral - biosynthesis | Head and Neck Neoplasms - prevention & control | Papillomaviridae - growth & development | Cancer Vaccines - administration & dosage | Cancer Vaccines - biosynthesis | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaccines, Subunit - immunology | Recombinant Fusion Proteins - chemistry | Head and Neck Neoplasms - pathology | Papillomaviridae - pathogenicity | Cancer Vaccines - immunology | Head and Neck Neoplasms - immunology | Animals | Vaccines, Subunit - biosynthesis | Antibodies, Neutralizing - biosynthesis | Papillomavirus Infections - prevention & control | Vaccines, Subunit - administration & dosage | Immunity, Humoral - drug effects | Recombinant Fusion Proteins - genetics | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Epitopes - chemistry | Mice | Oncogene Proteins, Viral - immunology | Capsid Proteins - genetics | Prevention | Vaccines | Viral proteins | Health aspects | Papillomavirus infections | Wildlife conservation | Peptides | Development and progression | Papillomaviruses | Warts | Sexually transmitted diseases | Analysis | Skin | Cervical cancer | Antigenic determinants | Human Papillomavirus (HPV) Vaccine | Cervical Cancer (CxCa) | Minor Capsid Protein (L2) | Squamous Cell Cancer (SCC) | cutaneous and anogenital warts (condylomata)
Journal Article